Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Saccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis &ndash; a review

1 Aug 2015

Abstract excerpt

The probiotic medicinal yeast Saccharomyces cerevisiae HANSEN CBS 5926 (Saccharomyces boulardii CNCM I-745) is used for the prevention and treatment of diarrhea. Its action is based on multiple mechanisms, including immunological effects, pathogen-binding and antitoxinic effects, as well as effects on digestive enzymes. Correlated with these effects, but also due to its inherent properties, S. boulardii is able...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clostridium difficile and Clostridium perfringens research
Share to Gut microbiota and health
Share to Probiotics and Fermented Foods

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26316791
DOI: 10.2147/ceg.s85574

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Saccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis &ndash; a reviewPMID 26316791Read ↗

Saccharomyces boulardii protects against murine experimental colitis by reshaping the gut microbiome and its metabolic profileSemantic proximity Read ↗

Emerging Trends in “Smart Probiotics”: Functional Consideration for the Development of Novel Health and Industrial ApplicationsSemantic proximity Read ↗

Probiotic yeasts: a developing reality?Semantic proximity Read ↗

Saccharomyces boulardii CNCM I-745 supplementation during and after antibiotic treatment positively influences the bacterial gut microbiotaSemantic proximity Read ↗

S. boulardii Early Intervention Maintains Gut Microbiome Structure and Promotes Gut Mucosal Barrier Function in Early-Weaned RatsSemantic proximity Read ↗

Synergistic Effect of Postbiotic Yeast ABB C22® on Gut Inflammation, Barrier Function and Protection from Rotavirus InfectionSemantic proximity Read ↗

Synergistic effect of postbiotic yeast ABB C22® on gut in-flammation, barrier function and protection from Rotavirus in-fectionSemantic proximity Read ↗

Multi-targeted properties of the probiotic saccharomyces cerevisiae CNCM I-3856 against enterotoxigenic escherichia coli (ETEC) H10407 pathogenesis across human gut modelsSemantic proximity Read ↗

Genomic and phenotypic comparison of <i>Saccharomyces cerevisiae</i> and <i>Saccharomyces boulardii</i>Semantic proximity Read ↗

Insight into the Possible Use of the Predator Bdellovibrio bacteriovorus as a ProbioticSemantic proximity Read ↗

Unveiling the probiotic potential of Enterococcus spp.: Mechanisms and roles in animal and human health, A comprehensive reviewSemantic proximity Read ↗

Effect of Clostridium butyricum on Gastrointestinal InfectionsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.